The Asia Pacific Pharmaceutical Gelatin Market would witness market growth of 6.2% CAGR during the forecast period (2022-2028).
Regenerative medicine is the amalgamation of molecular biology and tissue engineering. Its purpose is to repair and regenerate diseased or injured tissue using the patient’s own cells. In this area, gelatin helps in cell growth and imitates the extracellular matrix and hence acts as a useful biomaterial. It facilitates improved cell viability. It is necessary to minimize pyrogens and endotoxins in regenerative medicine, which is made possible with the use of gelatin after ensuring that it is highly purified. This ensures high performance and patient safety.
Thermoreversible ability at a temperature between 25°C and 32°C enables gelling grade gelatin to reverse melting and setting. Gelling-grade gelatin is a versatile material that has varied applications. One of the primary reasons for its versatility is the dependency of exact transition temperature on the type and concentration of gelatin that is used. Gelling grade gelatin’s bloom value measures the firmness of the gelled products. Due to the incapability to form a gel, a hydrolyzed gelatin possesses a bloom value of 0.
Further, gelatin, as a natural protein, furnish high biocompatibility and is well-bearable by the human body. Melting of gelatin at body temperature makes it applicable for the pharmaceutical industry, which is highly beneficial since it provides the best solutions to the problems where metabolization is required by pharma-medical.
The Chinese government is increasing its investment in R&D and healthcare. China’s pharmaceutical industry is growing due to its rising health awareness, total per capita expenditure on healthcare, and aging population. Whereas, in Japan, biopharmaceutical is responsible for around 15% of drug sales, and sales for biopharmaceutical are around 30% of all pharmaceutical sales globally. The rising pharmaceutical industry across the regional nations will also support the pharmaceutical gelatin market in the Asia Pacific region.
The China market dominated the Asia Pacific Pharmaceutical Gelatin Market by Country in 2021; thereby, achieving a market value of $139.9 million by 2028. The Japan market is registering a CAGR of 5.5% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 6.9% during (2022 - 2028).
Based on Type, the market is segmented into Type B and Type A. Based on Source, the market is segmented into Porcine, Bovine Skin, Bovine Bone, Marine, and Poultry. Based on Function, the market is segmented into Stabilizing Agent, Thickening Agent, and Gelling Agent & Others. Based on Application, the market is segmented into Hard Capsules, Softgel Capsules, Tablets, Absorbable Hemostats, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Australia, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Pharmaceutical Gelatin Market is Projected to reach USD 1.6 Billion by 2028, at a CAGR of 5.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Darling Ingredients, Inc., Nitta Gelatin, Inc., Tessenderlo Group nv, Gelita AG, SAS Gelatines Weishardt, Lonza Group Ltd. (Capsugel), Norland Products, Inc., Roxlor Group and Catalent, Inc.
By Type
By Source
By Function
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 